Skip to Content

MASLD and MASH: Clinical Spectrum and Modern Management, An Issue of Clinics in Liver Disease, 1st Edition

Author :
Edited by Zobair M. Younossi, MD, MPH, FACP, FACG, AGAF, FAASLD
In this issue of Clinics in Liver Disease, guest editor Dr. Zobair M. Younossi brings his considerable expertise to the topic of MASH/NASH Fatty Liver. With an estimated 115 million people worldwide affected by MASH, the disease burden casts a wide n ...view more
In this issue of Clinics in Liver Disease, guest editor Dr. Zobair M. Younossi brings his considerable expertise to the topic of MASH/NASH Fatty Liver. With an estimated 115 million people worldwide affected by MASH, the disease burden casts a wide net: many have other comorbidities, like diabetes, that make diagnosis and treatment critical. MASH-related liver cancer has increased 20% since 1990, and MASH is becoming a leading cause of liver transplants in adults, reflecting its significant impact on liver health. This issue provides state-of-the-art clinical reviews on MASH and NASH and also shines a light on the disease burden across the globe.
ISBN :
9780443413537
Publication Date :
28-05-2026
Stock Status :
Please allow 10-14 working days for delivery
Earn 11 Points
Earn 9 Points
Add to Cart
In this issue of Clinics in Liver Disease, guest editor Dr. Zobair M. Younossi brings his considerable expertise to the topic of MASH/NASH Fatty Liver. With an estimated 115 million people worldwide affected by MASH, the disease burden casts a wide net: many have other comorbidities, like diabetes, that make diagnosis and treatment critical. MASH-related liver cancer has increased 20% since 1990, and MASH is becoming a leading cause of liver transplants in adults, reflecting its significant impact on liver health. This issue provides state-of-the-art clinical reviews on MASH and NASH and also shines a light on the disease burden across the globe.

Key Features
  • Contains 19 relevant, practice-oriented topics including association of MASH with metabolic-related diseases (diabetes, pre-diabetes, and obesity); algorithms for risk stratification in patients with MASH; management of MASLD: lifestyle modification; currently approved and future regimens for MASH; pediatric MASH; and more
  • Provides in-depth clinical reviews on MASH/NASH fatty liver, offering actionable insights for clinical practice
  • Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews

Author Information
Edited by Zobair M. Younossi, MD, MPH, FACP, FACG, AGAF, FAASLD, Chairman, Department of Medicine, Inova Fairfax Hospital, Vice President for Research, Inova Health System, Professor of Medicine, VCU-Inova Campus, Beatty Center for Integrated Research, USA
More Information
ISBN Number 9780443413537
Description Author List Edited by Zobair M. Younossi, MD, MPH, FACP, FACG, AGAF, FAASLD, Chairman, Department of Medicine, Inova Fairfax Hospital, Vice President for Research, Inova Health System, Professor of Medicine, VCU-Inova Campus, Beatty Center for Integrated Research, USA
Copyright Year 2026
Edition Number 1
Format Book
Trim 152w x 229h (6.00" x 9.00")
Imprint Elsevier
Page Count 240
Publication Date 28 May 2026
Stock Status Please allow 10-14 working days for delivery

eBooks : Built for busy schedules & tailored for your goals.

Affordable knowledge, built for you

Get the resources you need-often at a lower cost than print. Quality content designed to support your goals, without stretching your budget.

Seamless access wherever you are

Open your eBook on your laptop, tablet, or phone - online or offline. Learning fits into your life, no matter where you go.

Always in sync

Start reading on one device and pick up right where you left off on another. Your progress and notes stay with you, every step of the way.

Tools the make learning stick

Highlight key points, take notes, create flashcards, or listen to your eBook read aloud. Interactive features help you deepen your knowledge, your way.

 

Your eBook is ready whenever you are!

1.  Check your email for your access code.

2.  Sign into or create your VitalSource account and redeem your code.

3.  Open your eBook - ready whenever you are!

FAQ

The access code for your new eBook will be sent in your order confirmation email. Your code can also be accessed in your My Account section on the Elsevier webshop. If you do not receive your code within a few minutes, please check your spam folder.


Step-by-step guidance on how to download Bookshelf and also redeem your code can be found here.


The access code for your new eBook does not expire. However, we always suggest redeeming immediately after purchase to start experiencing the benefits of and insights from your purchase. Important to note - the code provided is a single use code and only valid for the edition you purchase. It does not provide access to past nor future editions of the title.


You will have unlimited access to your eBook on the device to which it was downloaded.


Discover the various learning features that our eBooks offer on the Bookshelf® Reader! For example, you can highlight different text passages, create notes and flashcards, have the text read to you, etc. Particularly practical: You can also use your eBooks offline. More information on the learning functions can be found on the Vitalsource page.


Quality is our top priority. That's why we collaborate with the leading eBook reader provider VitalSource. VitalSource has its own eBook reader Bookshelf®, which you can easily download. This reader is very user-friendly and offers more features than other standard readers. For example, you can highlight different text passages, create notes and flashcards, have the text read to you, etc. Particularly practical: You can also use your eBooks offline. More information can be found on the Vitalsource page.


Elsevier offers its eBooks in ePub format, as we believe this format is best suited to display our content ideally on as many devices as possible.


You cannot return eBooks. If you have any questions, feel free to contact us.

Any questions ?

Support Center >

Top Picks from Our Community

Metabolic Dysfunction-Associated Steatotic Liver Disease: Global Epidemiology, Patient-Reported Outcomes, and Economic Impact
Association of Metabolic Dysfunction-Associated Steatohepatitis with Metabolic- Related Diseases: Diabetes, Prediabetes, and Obesity
Association of Metabolic Dysfunction-Associated Steatotic Liver Disease with Extrahepatic Cancers and Sarcopenia
Metabolic Liver Disease Beyond the Liver: Association of Metabolic Dysfunction- Associated Steatotic Liver Disease with Cardiovascular and Renal Diseases
Noninvasive Testing for Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
Algorithms for Risk Stratification in Patients with Metabolic Dysfunction- Associated Steatohepatitis
Management of Metabolic Dysfunction-Associated Steatotic Liver Disease with Lifestyle Modification
Treatment of Modifiable Risks in Metabolic Dysfunction-Associated Steatotic Liver Disease: Drugs Targeting Obesity and Type 2 Diabetes
Currently Approved and Future Regimens for Metabolic Dysfunction-Associated Steatohepatitis
Special Populations: Hepatocellular Carcinoma Risk and Liver Transplantation
Special Population: Lean MASH
Special Population: A Global Perspective on Metabolic Dysfunction-Associated Alcohol-Related Liver Disease
What’s New in Pediatric Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis
Metabolic Dysfunction-Associated Steatohepatitis in the Middle East: Clinical Challenges and Strategies to Bridge the Gap
Metabolic Dysfunction-Associated Steatotic Liver Disease in Asia: Epidemiology, Clinical Features, and Management
Metabolic Dysfunction-Associated Steatotic Liver Disease in Africa: From Burden to Action
Metabolic Dysfunction-Associated Steatotic Liver Disease in Latin America
Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Oceania, Central America, and the Caribbean
Metabolic Dysfunction-Associated Steatotic Liver Disease and Viral Hepatitis
Write Your Own Review
Only registered users can write reviews. Please sign in or create an account